Sivik Global Healthcare’s Insulet PODD Stock Holding History

Sivik Global Healthcare’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-25,000	Closed	-$5.04M	–	44
2024 Q2	$5.04M	Sell	25,000 -5,000	-17%	-$901K	1.81%	25
2024 Q1	$5.14M	Buy	30,000 +3,500	+13%	+$653K	1.21%	26
2023 Q4	$5.75M	Buy	26,500 +6,500	+33%	+$1.11M	2.4%	23
2023 Q3	$3.19M	Buy	+20,000	New	+$4.48M	1.61%	31
2018 Q1	–	Sell	-50,000	Closed	-$3.45M	–	66
2017 Q4	$3.45M	Buy	+50,000	New	+$3.28M	1.28%	36
2015 Q1	–	Sell	-39,400	Closed	-$1.81M	–	78
2014 Q4	$1.81M	Sell	39,400 -600	-2%	-$25.7K	0.74%	56
2014 Q3	$1.47M	Buy	40,000 +15,000	+60%	+$548K	0.67%	56
2014 Q2	$992K	Hold	25,000	–	–	0.5%	63
2014 Q1	$1.19M	Sell	25,000 -9,700	-28%	-$429K	0.74%	60
2013 Q4	$1.29M	Buy	+34,700	New	+$1.28M	0.91%	50

Other funds holding PODD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Sivik Global Healthcare's PODD Position: Q3 2024 in Review

Sivik Global Healthcare sold out of Insulet (PODD) in Q3 2024, closing a stake of 25,000 shares — an estimated $5.04M sold.

Sivik Global Healthcare first reported a position in PODD in Q4 2013 and held it in 10 quarters. The position peaked at $5.75M in Q4 2023. 623 funds tracked by Wall St. Rank hold PODD as of Q3 2024.

Sivik Global Healthcare reported no remaining Insulet position as of Q3 2024 after selling out during the quarter.
Sivik Global Healthcare sold 25,000 Insulet shares in Q3 2024, an estimated $5.04M.
Sivik Global Healthcare first reported a position in Insulet in Q4 2013 and held it in 10 quarters.
Sivik Global Healthcare's Insulet position peaked at $5.75M in Q4 2023.
623 funds tracked by Wall St. Rank held Insulet as of Q3 2024.

Based on Sivik Global Healthcare's 13F filing for Q3 2024, filed 6 Nov 2024.